The USPTO has announced a new pilot program applicable only to U.S. national stage applications that will require applicants ...
Nintendo's 'Summon and Fight' patent faces a rejection that raises questions about its scope and validity in the ongoing ...
On March 13, 2026, the U.S. Patent and Trademark Office (USPTO) published Supplemental Guidance for Examination of Design ...
US FDA issued a draft guidance for industry titled “New Clinical Investigation Exclusivity (3 years exclusivity) for drug products: Questions and answers.” The publication of this guidance has once ...
Section 702 of the Foreign Intelligence Surveillance Act is responsible for a huge share of intel collected by the U.S.
Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.